Publicacions destacades

• Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

  Iavarone M; Invernizzi F; Czauderna C; Sanduzzi-Zamparelli M; Bhoori S;

  (...)

  Varela M; Wörns MA; Bruix J; Lampertico P; Reig M .

  Veure llistat complet d'autors

  Referència:

  American Journal Of Transplantation 2019.

• Insights into the success and failure of systemic therapy for hepatocellular carcinoma

  Bruix J; da Fonseca LG; Reig M ;

  Referència:

  Nature Reviews Gastroenterology & Hepatology 2019.

• Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma

  Teufel M; Seidel H; Köchert K; Meinhardt G; Finn RS;

  Llovet JM; Bruix J .

  Referència:

  Gastroenterology 2019.

• Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib

  Díaz-González Á; Sanduzzi-Zamparelli M; Sapena V; Torres F; LLarch N;

  (...)

  Forner A; da Fonseca L; Ríos J; Bruix J; Reig M .

  Veure llistat complet d'autors

  Referència:

  Alimentary Pharmacology & Therapeutics 2019.

• Hepatocellular carcinoma

  Forner A; Reig M; Bruix J;

  Referència:

  Lancet 2018.

• Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

  Bruix, Jordi; Qin, Shukui; Merle, Philippe; Granito, Alessandro; Huang, Yi-Hsiang;

  (...)

  Finn, Richard S.; LeBerre, Marie-Aude; Baumhauer, Annette; Meinhardt, Gerold; Han, Guohong;Resorce Investigators.

  Veure llistat complet d'autors

  Referència:

  Lancet 2017.

• Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-beta pathway

  Boix, Loreto; Manuel Lopez-Oliva, Juan; Carolina Rhodes, Ana; Bruix, Jordi;;

  Referència:

  Oncotarget 2016.

• Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution

  Reig M; Mariño Z; Perelló C; Iñarrairaegui M; Ribeiro A;

  (...)

  Varela M; Sangro B; Calleja JL; Forns X; Bruix J .

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2016.

• Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection

  Ferrer-Fabrega, Joana; Forner, Alejandro; Liccioni, Alexandre; Miquel, Rosa; Molina, Victor;

  Navasa, Miquel; Fondevila, Constantino; Carlos Garcia-Valdecasas, Juan; Bruix, Jordi; Fuster, Josep;.

  Referència:

  Hepatology 2016.